Former BioNTech clinical trial manager sues the company, alleging protocol deviations and patient safety lapses in a pancreatic cancer trial.
A former senior clinical trial manager at BioNTech sued the German company in North Carolina district court on Monday, alleging protocol deviations and other safety …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its…
A newly unsealed whistleblower lawsuit accuses Novartis and Genentech of being at the center of a decades-long kickback scheme to…
A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor progression by…
Lacks' cells were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements,…
NEJM retracts pivotal data behind Amgen's Tavneos after FDA probe finds results for 9 patients re-evaluated post-unblinding; EU…
Overprescribing of temozolomide left some people with secondary cancer and other severe side-effects, say lawyers
